Open access peer-reviewed chapter

An Overall View of the Regulation of Hepatic Lipid Metabolism in Chicken Revealed by New-Generation Sequencing

Written By

Hong Li, Zhuanjian Li and Xiaojun Liu

Submitted: December 7th, 2015 Reviewed: July 20th, 2016 Published: February 15th, 2017

DOI: 10.5772/64970

Chapter metrics overview

2,016 Chapter Downloads

View Full Metrics


In chickens, more than 90% of the de novo synthesis of fatty acids occurs in the liver; therefore, the liver metabolism has a critical effect on chicken development and egg laying performance. Although the physiological processes of liver lipid metabolism have been studied extensively in chicken, the underlying mechanisms and the roles of noncoding RNAs in the process remain ambiguous. Recently, we investigated the regulatory mechanism of hepatic lipid in chicken by new generation sequencing technology. Our results uncovered many genes, which play crucial roles in mammal lipid metabolism process, might have different biological functions in chicken. Some other genes which might play essential roles in chicken hepatic lipid metabolism were found. In addition, the physiological processes of hepatic lipid metabolism in chicken are regulated by noncoding RNAs, such as miRNAs and lncRNAs.


  • lipid metabolism
  • new generation sequencing
  • miRNA
  • lncRNA
  • chicken

1. Introduction

The molecular regulatory mechanisms of the hepatic lipids in domestic chicken had been largely established after being extensively studied (see reviews [15]). In recent years, however, with research advances in genomics, epigenomics and related fields such as systematic biology and bioinformatics, and also with the development of advanced techniques such as new generation sequencing and computation programming, our knowledge about gene regulation and interactions has been considerably widened. As a result, the following questions about synthesis, formation and transport of yolk precursors in liver of laying hens remains to be fully elucidated.

First, what enzymes actually catalyze lipids synthesis in laying hen liver? In comparison with mammals, liver is the major site of lipid biosynthesis in the chicken [68]. Though most of the chicken genes and their products involved in the hepatic lipid metabolism are highly similar to those in mammals including human, their specialized tasks were considerably different [912]. For instance, a recent study on lysophosphatidylglycerol acyltransferase 1 (LPGAT1) indicated that LPGAT1 has a role in lipid synthesis in mice [13]. Our studies revealed, however, LPGAT1 has no significant effect on lipid synthesis with estrogen induction in chicken. In addition, some of the genes related to lipid metabolism had been lost in chicken during evolutionary process [14]. Therefore, the range of genes and their products involved in the hepatic lipid metabolism in laying hen remain to be fully elucidated [8].

Second, how are the very low density lipoprotein (VLDL) particles assembled and secreted in the liver of chicken? In mammals, it was well documented that microsomal triglyceride transfer protein (MTTP) assists in lipoprotein assembly to form very low density lipoprotein [13, 1519]. The formation of VLDL particles in avian species is tightly regulated by estrogen. However, recent study has proved that upregulation of MTTP in the liver is not required for the increased VLDL assembly during egg production in the chicken [20]. Our study on MTTP expression levels in livers between pre-laying and egg-laying hens also showed no difference though that the liver ApoB and ApoVLDL II expression levels and plasma VLDL level were elevated dramatically in laying hen.

Third, how does the estrogen induce lipid synthesis and transfer processes in liver of laying hen regulated by noncoding RNA? It is now well appreciated that a large portion of the eukaryotic genome gives rise to non-protein-coding RNAs (ncRNAs) of various sizes ranging from ~20 nucleotides to ~100 kb, which are predicted to play essential roles in a variety of biological processes (see reviews [2124]). Among ncRNAs, microRNAs (miRNAs) and long ncRNAs (lncRNAs) attracted more researches’ attention.

MiRNAs are short, being composed of only 18–25 nucleotides (nt) single-stranded RNAs, which was first described in 1993 [25]. Since then, the view of gene expression regulation has been dramatically altered. MiRNAs are reported to regulate gene expression at the posttranscriptional level through RNA interference (RNAi) pathways [26]. In general, miRNAs interact with mRNAs to perform their functions. It has been argued that one miRNAs can regulate the expression of hundreds of mRNAs, while the expression of one mRNA could be regulated simultaneously by hundreds of miRNAs [27]. In other words, miRNAs can play critical roles through constructing networks of sophisticated regulatory systems in organisms [28]. Currently, many varieties of miRNAs are widely reported in plants, animals and even microbes. Alterations of specific miRNA levels have significant correlation with changes of physiological or pathological functions of divergent origin.

LncRNAs are RNA polymerase II (RNAPII) transcripts that are longer than 200 nucleotides [29, 30], which may regulate protein-coding gene expression at both the transcriptional and posttranscriptional levels. Transcription regulated by lncRNAs could negatively or positively control protein-coding gene expression either in cis or in trans [31]. Posttranscriptional regulation by lncRNAs could also negatively or positively control protein coding gene expression through competing endogenous RNAs, modulating mRNA stability and translation by homologous base pairing, or acting as nuclear retention of mRNAs [32]. A growing number of lncRNAs have recently been described, and their functions are been uncovering.

Therefore, the objective of this chapter is going to give an overview of the molecules regulation of hepatic lipid metabolism in chicken, which was based on the studies performed by using the new generation sequencing technology.


2. Genes involved in hepatic lipid metabolism in chicken

Liver as the most important metabolic organ where up to 90% of fatty acids are de novo synthesized in chicken [3335]. It was found that the onset of laying in the poultry is preceded by large increase in the plasma-free fatty acids, lipids and phosphoproteins [36]. We used the pre-laying hens (20-week old) and egg-laying hens (30-week old) of Lushi green-shelled-egg chickens as the experiment model, and the most obvious physiological difference between the two stages is laying egg or not. Three pre-laying hens and three egg-laying hens, which were raised in cages under the same environmental conditions with ad libitum to food and water, were slaughtered. Liver tissues were harvested immediately and the RNA from the liver samples was extracted. The new generation sequencing technology was used to establish the gene expression profile [37]. Bioinformatic analysis methods were used to explore the genes involved in hepatic lipid metabolism, and uncover the regulatory mechanism of hepatic lipid metabolism in chicken.

In our research results, compared to pre-laying hen, there were 960 significant differentially expressed (SDE) genes obtained in the liver of egg-laying hen [37]. Among those SDE genes, many ones were enriched in lipid metabolism pathways (Figure 1).

Figure 1.

The SDE genes significantly enriched in lipid metabolism pathways. Note: The number on each bar means the number of genes enriched in the pathway.

For example, stearoyl-CoA desaturase 1 (SCD-1) is a rate limiting enzyme of monounsaturated fatty acid synthesis in liver and upregulated in egg-laying hens compared with pre-laying hens. Bioinformatic analysis showed it was enriched in the lipogenesis of the peroxisomeproliferator-activated receptor (PPAR) signaling pathway, and the mRNA expression and activity of SCD-1 have been shown to be triggered by insulin to promote fat synthesis [38]. Interestingly, a very recent study demonstrated that B-cell translocation gene 1 (BTG1) overexpression inhibited the expression of SCD-1 gene and altered hepatic lipid metabolism by decreased triglyceride accumulation in human [39]. However, our data showed that BTG1 expression level also significantly increased when the SCD-1 gene expression level elevated in egg-laying hens. It suggests that expression of SCD-1 gene is regulated in different ways in chicken. The FABP1 and FABP3, which are involved in hepatic fatty acid oxidation [40, 41], intracellular fatty acid transport [42], storage and export, as well as in cholesterol and phospholipid metabolism [4345], were both significantly upregulated in the liver of egg-laying hens compared with pre-laying hens. They may promote lipid metabolism through the PPAR signaling pathway to meet the requirements of laying eggs. Some transcriptional factors such as sterol regulatory element binding protein (SREBP-1) and fatty acid synthase (FASN) genes were found to be elevated coordinately in egg-laying chicken liver that could synthesize fatty acids de novo [46]. Meanwhile, some novel genes and alternative splicing isoforms were also found to be differentially expressed and predicted to be relevant with lipid associated processes [37].

In the de novo fatty acids synthesis process, some key genes reported to be important in regulating lipid metabolism in mammals, but do not play the same roles in chicken (Figure 2). It is well documented that the triacylglycerol (TG) is postulated to synthesize through two biosynthetic pathways in liver. One is called glycerophosphate pathway, the other is monoacylglycerol pathway [47]. In the glycerophosphate pathway, TG is synthesized from the small precursor molecule glycerol-3-phosphate (G3P) and through the precursor phosphatidic acid (PA). The sequential reactions of acyl-CoA: G3P acyltransferase (GPAT) and acyl-CoA: 1-acyl-G3P acyltransferase (AGPAT) are involved in the incorporation of fatty acids into the glycerol backbone of phospholipids [47]. Glycerol-3-phosphate acyltransferase mitochondrial (GPAM) is an enzyme that plays a central role in de novo lipogenesis. The diacylglycerols (DG) is generated by PA dephosphorylation [48], and this process can be influenced by lipins [48, 49], which define a family of Mg2+-dependent PA3 phosphatase enzymes with key roles in lipid metabolism [50]. Lipins have different expression patterns in different species, only one lipin in fungi, flies and worms [51], and three lipins including lipin1, 2 and 3 in mammals [52]. The DG can also be synthesized from monoacylglycerol (MG) catalyzed by Acyl-CoA:monoacylglycerol acyltransferase (MOGAT) family including MOGT1, MOGT2 and MOGT3 in mammals. In addition, LPGAT1 involves in triacylglycerol synthesis and secretion in liver [53] and promotes hepatic lipogenesis in mice [54]. In our study, compared to pre-laying hens, the expression levels GPAM, AGPAT2, AGPAT3, lipin1 and lipin2 genes were significantly upregulated in egg-laying hens. It suggested that these enzymes may play key roles in TG biosynthesis in the liver of chicken. However, some of the enzyme genes such as GPAT2, AGPAT4, AGPAT5 and AGPAT6 showed no changes in their expression levels, and some genes such as AGPAT9, MOGAT1 and LPGAT1 even exhibited down-regulated expression patterns. The other enzyme family members, which existed in mammals, were not detected in our animal model. Clearly, genes related to specific functions in regulating fatty acid synthesis are significantly different between mammals and avian species.

Figure 2.

Expression pattern of key genes involved in chicken lipid metabolism. Note: NS means gene not significant differentially expressed in our RNA-seq results; up-arrow means gene up-regulated, down-arrow means down-regulated.

The final step in the de novo synthesis of TG is catalyzed by acyl-CoA: diacylglycerol acyltransferase (DGAT) enzymes, including DGAT1 and DGAT2 [55]. Overexpression of human DGAT1 in McA-RH7777 cells can result in increasing the synthesis, accumulation and secretion of TG and VLDL [56]. Due to majority of the TG destined for secretion by liver is synthesized by DGAT2 [57], expression of DGAT2 in McA-RH7777 cells is positively related with the secretion of TG and apoB [56, 57]. However, the DGAT1 gene was not expressed in chicken liver, and the expression level of DGAT2 was not changed between the pre- and egg-laying hens. Another member of DGAT family, SOAT1 (sterol O-acyltransferase 1) even was down-regulated. It implied that there must be some other gene(s) involved in the process. Interestingly, a novel gene designated DGAT2-like gene, which possesses essential domains as does DGAT2, was identified and found to be significantly upregulated in egg-laying hens. This result suggests that DGAT2-like may play the role catalyzing TG formation in the liver of chicken as DGAT2 does in mammals.

The MTTP assists in lipoprotein assembly to form low density lipoprotein [54, 5862], and highly related with VLDL assembly and lipoprotein particle secretion [63, 64]. However, a previous study demonstrated that the upregulation of MTTP in liver was not required for increasing VLDL assembly during the laying period in chicken [20]. Same to the above result, our study also indicated that the MTTP was not significant differentially expressed in the liver of egg-laying hens in comparison to pre-laying hens. It implies that MTTP–like does not act the role as it does in mammals. As we expected, a novel gene-designated MTTP-like, which contains all the essential domains and motifs as MTTP does, was found to be significantly upregulated in egg-laying hens. Estrogen induction studies both in vivo and in vitro further revealed that the MTTP-like expression was regulated by estrogen in a dose dependent manner in liver of chicken. Although most the current findings appear to be consistent with the conservation of lipid metabolism in chicken and mammal, species-specific differences should be considered when comparing chicken with mammalian systems. The chicken liver transcriptome reported here could greatly broaden our understanding of the regulation and network of gene expression related to liver lipid metabolism in chicken at different physiological stages.


3. Regulation of hepatic lipid metabolism by ncRNAs in chicken

Lipid synthesis and transfer are dynamic and complex processes, which can be steered by various regulatory factors. During the egg-laying period, the estrogen level of hens goes up significantly and promotes the liver to synthesize egg yolk precursors. It was reported that estrogen can dramatically stimulate hepatic synthesis of apoB [65] and induce the de novo synthesis of the reproduction-specific apolipoprotein and apoVLDL-II in poultry by enhancing the accumulation of the mRNAs [66]. Our findings are consistent with previous reports that apoB and apoVLDL-II were significantly increased in the liver of egg-laying chicken compared with pre-laying hens (Figure 3). The increase in expression levels of apoB, apoVLDL-II and many other genes are supposed to be induced by estrogen. However, some upregulated genes such as sirtuin isoforms (Sirt 1-7) in egg-laying hens seems to be regulated by other factors instead of estrogen, because the expression levels of these genes in chicken liver tended to be decreased when chicken or chicken embryonic hepatic cells were treat with estrogen (unpublished data,related article is under reviewing).

Figure 3.

The expression of genes in 20- and 30-week-old hens.

MiRNA as a kind of posttranscriptional regulatory factor are reported to serve as important roles in lipid metabolism. It was identified that both gga-miR-148a and miR-122 are highly abundant miRNA in chicken hepatocytes [67] and in porcine liver [68]. A liver-specific miR-122 with high expression abundance in mammalian liver could modulate the hepatic fatty acids and cholesterol synthesis through repressing the expression of genes involved in cholesterol biosynthesis [69, 70]. MiR-33 involves in liver metabolism by regulating cholesterol efflux and high density lipoprotein metabolism by targeting the ATP-binding cassette subfamily A member 1 and ATP-binding cassette subfamily G member 1 [71]. These implied that some miRNAs may also involve in regulating chicken hepatic lipid metabolism through binding their target genes.

Considering the obvious difference of physiological activities between pre- and egg-laying stages, the pre- and egg-laying hens experiment model used in RNA-seq research [37] was used to investigate the critical miRNAs that may regulate the lipid metabolism. Bioinformatic analysis methods were used to explore the differentially expressed miRNAs involved in hepatic lipid metabolism and uncover the regulation ways of hepatic lipid metabolism in chicken [72]. Our results showed that majority of the target genes of down-regulated miRNAs significantly enriched in lipid metabolism-related processes, and enzyme activity, iron, vitamin binding molecular function (Figure 4). It is consistent with the event that eggs are rich in essential amino acids and fatty acids, as well as of some minerals and vitamins [73]. Our results suggest that the differentially expressed miRNAs may participate in chicken hepatic lipid metabolism through acting with their target genes.

Figure 4.

The significantly enriched and lipid-related GO terms of the target genes of the down-regulated miRNAs.

LncRNA is a class of pervasive genes involved in a variety of biological functions. Increasing researches present some lncRNAs are contributed to liver relevant metabolisms, including lipid metabolism. LncLGRAs, the transcriptional regulation factor of hepatic glucokinase (GCK) gene, can inhibit the expression of GCK and reduce hepatic glycogen content in mice during fasting [74]. It is reported that, whether enhanced the expression of lncRNA MALAT1 in vivo or in vitro, it can activate the nuclear SREBP1c expression and induce the intracellular lipid accumulation in mouse hepatocytes [75], while the lncRNAs that may take part in chicken hepatic lipid metabolism are unknown. Therefore, to gain insight into the underlying roles of lncRNAs serving as the hepatic lipid metabolism regulatory molecules, a lncRNA-Seq has be conducted to the livers of pre- and egg-laying hens to detect the lncRNAs.


4. Future perspectives

As well known, both lncRNAs and miRNAs serve as the endogenously expressed regulators of gene expression [76]. Recent researches have showed that the aberrant expression of lncRNAs and transcription factors can result in the miRNAs disorder. A study has demonstrated that a highly upregulated liver cancer lncRNA could serve as an endogenous sponge, which can down-regulate a series of miRNAs activities [77]. Due to the long size of lncRNAs, it regulate miRNA abundance via binding and sequestering them, working as the so-called miRNAs sponges, thus regulating the expression of target mRNAs [78, 79]. Given the complex modulation network among mRNAs [37], miRNAs [72] and lncRNAs, it will be great interest for us to combine these data sets to explore the possible regulation mechanisms among lncRNA, mRNA and miRNA. Our results will be a valuable resource for further elucidating the regulatory mechanism of chicken hepatic lipid metabolism and may also provide reference for understanding the molecular mechanisms in other poultry and mammalian species.

It has to be mentioned that the regulation of hepatic lipid metabolism in chicken described in this chapter is based on comparative studies between pre- and egg-laying hens, in which estrogen is supposed to be the main factor influencing lipid metabolism. In fact, many other factors such as feed additives and photogenic compounds may also play important roles in the lipid metabolism process, while the regulatory mechanism that genes involved in may not be the same as the present results [8082].


  1. 1. Schneider WJ. Yolk precursor transport in the laying hen. Current Opinion in Lipidology. 1995;6(2):92–6.
  2. 2. Bujo H, Hermann M, Lindstedt KA, Nimpf J, Schneider WJ. Low density lipoprotein receptor gene family members mediate yolk deposition. The Journal of Nutrition. 1997;127(5 Suppl.):801S–4S.
  3. 3. Schneider WJ. Low density lipoprotein receptor relatives in chicken ovarian follicle and oocyte development. Cytogenetic and Genome Research. 2007;117(1–4):248–55.
  4. 4. Schneider WJ. Receptor-mediated mechanisms in ovarian follicle and oocyte development. General and Comparative Endocrinology. 2009;163(1–2):18–23.
  5. 5. Stein Y, Stein O. Serum lipoproteins and the liver, synthesis and catabolism. Hormone and Metabolic Research. 1974;Suppl.Ser.4:16–23.
  6. 6. Waterman RA, Romsos DR, Tsai AC, Miller ER, Leveille GA. Effects of dietary carbohydrate source on growth, plasma metabolites and lipogenesis in rats, pigs, and chicks. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. 1975;150(1):220–5.
  7. 7. Leveille GA, Romsos DR, Yeh Y, O’Hea EK. Lipid biosynthesis in the chick. A consideration of site of synthesis, influence of diet and possible regulatory mechanisms. Poultry Science. 1975;54(4):1075–93.
  8. 8. Riegler B, Besenboeck C, Bauer R, Nimpf J, Schneider WJ. Enzymes involved in hepatic acylglycerol metabolism in the chicken. Biochemical and Biophysical Research Communications. 2011;406(2):257–61.
  9. 9. Kirchgessner TG, Heinzmann C, Svenson KL, Gordon DA, Nicosia M, Lebherz HG, et al. Regulation of chicken apolipoprotein B: cloning, tissue distribution, and estrogen induction of mRNA. Gene. 1987;59(2–3):241–51.
  10. 10. Wiskocil R, Bensky P, Dower W, Goldberger RF, Gordon JI, Deeley RG. Coordinate regulation of two estrogen-dependent genes in avian liver. Proceedings of the National Academy of Sciences of the United States of America. 1980;77(8):4474–8.
  11. 11. Hermier D, Catheline D, Legrand P. Relationship between hepatic fatty acid desaturation and lipid secretion in the estrogenized chicken. Comparative Biochemistry and Physiology Part A, Physiology. 1996;115(3):259–64.
  12. 12. Mason TM. The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes. Critical Reviews in Clinical Laboratory Sciences. 1998;35(6):461–87.
  13. 13. Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nature Medicine. 2013;19(7):892–900.
  14. 14. Dakovic N, Terezol M, Pitel F, Maillard V, Elis S, Leroux S, et al. The loss of adipokine genes in the chicken genome and implications for insulin metabolism. Molecular Biology and Evolution. 2014;31(10):2637–46.
  15. 15. Hussain MM, Rava P, Pan X, Dai K, Dougan SK, Iqbal J, et al. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Current Opinion in Lipidology. 2008;19(3):277–84.
  16. 16. Hussain MM, Iqbal J, Anwar K, Rava P, Dai K. Microsomal triglyceride transfer protein: a multifunctional protein. Frontiers in Bioscience: A Journal and Virtual Library. 2003;8:s500–6.
  17. 17. Hussain MM, Rava P, Walsh M, Rana M, Iqbal J. Multiple functions of microsomal triglyceride transfer protein. Journal of Nutrition and Metabolism. 2012;9:14.
  18. 18. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annual Review of Nutrition. 2000;20:663–97.
  19. 19. Rustaeus S, Lindberg K, Stillemark P, Claesson C, Asp L, Larsson T, et al. Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation. The Journal of Nutrition. 1999;129(2S Suppl.):463S–6S.
  20. 20. Ivessa NE, Rehberg E, Kienzle B, Seif F, Hermann R, Hermann M, et al. Molecular cloning, expression, and hormonal regulation of the chicken microsomal triglyceride transfer protein. Gene. 2013;523(1):1–9.
  21. 21. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–8.
  22. 22. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nature Reviews Genetics. 2009;10(3):155–9.
  23. 23. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes & Development. 2009;23(13):1494–504.
  24. 24. Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nature Reviews Genetics. 2011;12(2):136–49.
  25. 25. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.
  26. 26. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–8.
  27. 27. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nature Genetics. 2005;37(5):495–500.
  28. 28. Wang X, Yu J, Zhang Y, Gong D, Gu Z. Identification and characterization of microRNA from chicken adipose tissue and skeletal muscle. Poultry Science. 2012;91(1):139–49.
  29. 29. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Research. 2012;22(9):1775–89.
  30. 30. Perkel JM. Visiting “noncodarnia”. BioTechniques. 2013;54(6):301, 303, 304.
  31. 31. Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene regulation by the act of long non-coding RNA transcription. BMC Biology. 2013;11:59.
  32. 32. Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. Journal of Molecular Biology. 2013;425(19):3723–30.
  33. 33. Leveille GA, O’Hea EK, Chakrabarty K. In vivo lipogenesis in the domestic chicken. Experimental Biology and Medicine. 1968;128(2):398–401.
  34. 34. O’hea E, Leveille G. Lipogenesis in isolated adipose tissue of the domestic chick (Gallus domesticus). Comparative Biochemistry and Physiology. 1968;26(1):111–20.
  35. 35. O’hea E, Leveille G. Lipid biosynthesis and transport in the domestic chick (Gallus domesticus). Comparative Biochemistry and Physiology. 1969;30(1):149–59.
  36. 36. Heald P, Badman H. Lipid metabolism and the laying hen: I. Plasma-free fatty acids and the onset of laying in the domestic fowl. Biochimica et Biophysica Acta (BBA)-Specialized Section on Lipids and Related Subjects. 1963;70:381–8.
  37. 37. Li H, Wang T, Xu C, Wang D, Ren J, Li Y, et al. Transcriptome profile of liver at different physiological stages reveals potential mode for lipid metabolism in laying hens. BMC Genomics. 2015;16(1):763.
  38. 38. Lefevre P, Diot C, Legrand P, Douaire M. Hormonal regulation of stearoyl coenzyme-A desaturase 1 activity and gene expression in primary cultures of chicken hepatocytes. Archives of Biochemistry and Biophysics. 1999;368(2):329–37.
  39. 39. Xiao F, Deng J, Guo Y, Niu Y, Yuan F, Yu J, et al. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism. Science Signaling. 2016;9(428):ra50–ra.
  40. 40. Veerkamp J. Fatty acid-binding protein and its relation to fatty acid oxidation. Molecular and Cell Biology. 1993;123:101–6.
  41. 41. Kaikaus RM, Sui Z, Lysenko N, Wu NY, de Montellano PO, Ockner R, et al. Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine palmitoyltransferase I. Journal of Biological Chemistry. 1993;268(36):26866–71.
  42. 42. Woodford J, Behnke W, Schroeder F. Liver fatty acid binding protein enhances sterol transfer by membrane interaction. Molecular and Cellular Biochemistry. 1995;152(1):51–62.
  43. 43. Jefferson J, Powell D, Rymaszewski Z, Kukowska-Latallo J, Lowe J, Schroeder F. Altered membrane structure in transfected mouse L-cell fibroblasts expressing rat liver fatty acid-binding protein. Journal of Biological Chemistry. 1990;265(19):11062–8.
  44. 44. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, Bader M, et al. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. Journal of Biological Chemistry. 2003;278(24):21429–38.
  45. 45. Atshaves BP, McIntosh AM, Lyuksyutova OI, Zipfel W, Webb WW, Schroeder F. Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. Journal of Biological Chemistry. 2004;279(30):30954–65.
  46. 46. Gondret F, Ferré P, Dugail I. ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species. Journal of Lipid Research. 2001;42(1):106–13.
  47. 47. Yamashita A, Hayashi Y, Nemoto-Sasaki Y, Ito M, Oka S, Tanikawa T, et al. Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms. Progress in Lipid Research. 2014;53:18–81.
  48. 48. Nadra K, de Preux Charles A-S, Médard J-J, Hendriks WT, Han G-S, Grès S, et al. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes & Development. 2008;22(12):1647–61.
  49. 49. Brindley DN, Pilquil C, Sariahmetoglu M, Reue K. Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2009;1791(9):956–61.
  50. 50. Han G-S, Wu W-I, Carman GM. The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. Journal of Biological Chemistry. 2006;281(14):9210–8.
  51. 51. Péterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nature Genetics. 2001;27(1):121–4.
  52. 52. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. Journal of Biological Chemistry. 2007;282(6):3450–7.
  53. 53. Hiramine Y, Emoto H, Takasuga S, Hiramatsu R. Novel acyl-coenzyme A: monoacylglycerol acyltransferase plays an important role in hepatic triacylglycerol secretion. Journal of Lipid Research. 2010;51(6):1424–31.
  54. 54. Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nature Medicine. 2013;19(7):892–900.
  55. 55. Walther TC, Farese Jr RV. Lipid droplets and cellular lipid metabolism. Annual Review of Biochemistry. 2012;81:687.
  56. 56. Liang JJ, Oelkers P, Guo C, Chu P-C, Dixon JL, Ginsberg HN, et al. Overexpression of human diacylglycerol acyltransferase 1, acyl-coa: cholesterol acyltransferase 1, or acyl-CoA: cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells. Journal of Biological Chemistry. 2004;279(43):44938–44.
  57. 57. Liu Y, Millar JS, Cromley DA, Graham M, Crooke R, Billheimer JT, et al. Knockdown of acyl-CoA: diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2008;1781(3):97–104.
  58. 58. Hussain MM, Rava P, Walsh M, Rana M, Iqbal J. Multiple functions of microsomal triglyceride transfer protein. Nutrition & Metabolism. 2012;9(1):1.
  59. 59. Hussain MM, Rava P, Pan X, Dai K, Dougan SK, Iqbal J, et al. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Current Opinion in Lipidology. 2008;19(3):277–84.
  60. 60. Hussain MM, Iqbal J, Anwar K, Rava P, Dai K. Microsomal triglyceride transfer protein: a multifunctional protein. Front Biosci. 2003;8:s500–6.
  61. 61. Berriot-Varoqueaux N, Aggerbeck L, Samson-Bouma M-E, Wetterau J. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annual Review of Nutrition. 2000;20(1):663–97.
  62. 62. Rustaeus S, Lindberg K, Stillemark P, Claesson C, Asp L, Larsson T, et al. Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation. The Journal of Nutrition. 1999;129(2):463S–6S.
  63. 63. Gordon DA, Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2000;1486(1):72–83.
  64. 64. Gordon DA, Wetterau JR, Gregg RE. Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles. Trends in Cell Biology. 1995;5(8):317–21.
  65. 65. Kudzma DJ, Swaney JB, Ellis EN. Effects of estrogen administration on the lipoproteins and apoproteins of the chicken. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism. 1979;572(2):257–68.
  66. 66. Chan L, Jackson R, O’malley B, Means A. Synthesis of very low density lipoproteins in the cockerel. Effects of estrogen. Journal of Clinical Investigation. 1976;58(2):368.
  67. 67. Wang X, Yang L, Wang H, Shao F, Yu J, Jiang H, et al. Growth hormone-regulated mRNAs and miRNAs in chicken hepatocytes. PLoS One. 2014;9(11): e112896.
  68. 68. Xie S-S, Li X-Y, Liu T, Cao J-H, Zhong Q, Zhao S-H. Discovery of porcine microRNAs in multiple tissues by a Solexa deep sequencing approach. PLoS One. 2011;6(1):e16235.
  69. 69. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism. 2006;3(2):87–98.
  70. 70. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 2005;438(7068):685–9.
  71. 71. Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328(5985):1570–3.
  72. 72. Hong Li, Zheng Ma, Lijuan Jia, Yanmin Li, Chunlin Xu, Taian Wang, Ruili Han, Ruirui Jiang, Zhuanjian Li, Guirong Sun, Xiangtao Kang, Xiaojun Liu. Systematic analysis of the regulatory functions of microRNAs in chicken hepatic lipid metabolism. Scientific Reports. 2016; 6:31766.
  73. 73. McNamara D, Thesmar H. Eggs. Egg Nutrition Center: Washington, DC, USA. 2005.
  74. 74. Ruan X, Li P, Cangelosi A, Yang L, Cao H. A long non-coding RNA, lncLGR, regulates hepatic glucokinase expression and glycogen storage during fasting. Cell Reports. 2016;14(8):1867–1875.
  75. 75. Yan C, Chen J, Chen N. Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability. Scientific Reports. 2016;6:22640.
  76. 76. Kaur P, Liu F, Tan JR, Lim KY, Sepramaniam S, Karolina DS, et al. Non-coding RNAs as potential neuroprotectants against ischemic brain injury. Brain Sciences. 2013;3(1):360–95.
  77. 77. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Research. 2010;38(16):5366–83.
  78. 78. Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S. Bioinformatics method to predict two regulation mechanism: TF–miRNA–mRNA and lncRNA–miRNA–mRNA in pancreatic cancer. Cell Biochemistry and Biophysics. 2014;70(3):1849–58.
  79. 79. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358–69.
  80. 80. Li XL, He WL, Wang ZB, Xu TS. Effects of Chinese herbal mixture on performance, egg quality and blood biochemical parameters of laying hens. Journal of Animal Physiology and Animal Nutrition (Berl). 2016; doi:10.1111/jpn.12473.
  81. 81. Gholami-Ahangaran M, Rangsaz N, Azizi S. Evaluation of turmeric (Curcuma longa) effect on biochemical and pathological parameters of liver and kidney in chicken aflatoxicosis. Pharmaceutical Biology. 2016;54(5):780–7.
  82. 82. Ryu ST, Park B, Bang HT, Kang HK, Hwangbo J. Effects of anti-heat diet and inverse lighting on growth performance, immune organ, microorganism and short chain fatty acids of broiler chickens under heat stress. Environmental Biology. 2016;37(2):185–92.

Written By

Hong Li, Zhuanjian Li and Xiaojun Liu

Submitted: December 7th, 2015 Reviewed: July 20th, 2016 Published: February 15th, 2017